The role of ncRNAs-mediated pyroptosis in diabetes and its vascular complications

Cell Biochem Funct. 2024 Mar;42(2):e3968. doi: 10.1002/cbf.3968.

Abstract

Over the past decade, the prevalence of diabetes has increased significantly worldwide, leading to an increase in vascular complications of diabetes (VCD), such as diabetic cardiomyopathy (DCM), diabetic nephropathy (DN), and diabetic retinopathy (DR). Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs), long Noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), play a key role in cellular processes, including the pathophysiology of diabetes and VCD via pyroptosis. ncRNAs (e.g., miR-17, lnc-MEG3, and lnc-KCNQ1OT1) can regulate pyroptosis in pancreatic β cells. Some ncRNAs are involved in VCD progression. For example, miR-21, lnc-KCNQ1OT1, lnc-GAS5, and lnc-MALAT1 were reported in DN and DCM, and lnc-MIAT was identified in DCM and DR. Herein, this review aimed to summarize recent research findings related to ncRNAs-mediated pyroptosis at the onset and progression of diabetes and VCD.

Keywords: diabetes; noncoding RNAs; pyroptosis; vascular complications of diabetes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus* / genetics
  • Diabetic Cardiomyopathies* / genetics
  • Diabetic Nephropathies* / genetics
  • Humans
  • MicroRNAs* / genetics
  • Pyroptosis
  • RNA, Untranslated / genetics

Substances

  • RNA, Untranslated
  • MicroRNAs